Singapore-based social network for medical professionals Docquity reportedly has raised US$11 million Series B funding led by Japan’s Itochu Corporation with US$6 million in investment, and Singapore Press Holdings.

Other investors in the round include Singapore’s SPH Ventures and KDV Holdings and Zigexn Japan CEO Jo Hirao, as reported by Deal Street Asia.

Also Read: SoftBank to inject US$500M fund to back early-stage startups

Docquity has just closed its Series A funding seven months ago, led by Japanese early stage investor Genesia Ventures.

Docquity was founded in 2015 with a premise of a mobile app for doctors and physicians to find, connect, and collaborate with trusted peers, specialists, and other professionals over a secure platform. The revenue model on the platform is done by letting pharmaceutical companies advertise their products on its platform.

Docquity notes that over 70,000 real-world clinical cases have been shared and discussed by over 80,000 verified doctors on its network. The fee-free platform does its doctor verification process through its partnership with National Medical Associations across Southeast Asia.

Also Read: The rise of gig economy and how it affects fintech

To date, Docquity has presences in seven countries including Indonesia and the Philippines. It says that it’s now working with hospitals and specialised medical societies in the region to expand and create specialised discussion communities.